CO2019012771A2 - Diagnostic assays to detect, quantify, and / or trace microbes and other analytes - Google Patents

Diagnostic assays to detect, quantify, and / or trace microbes and other analytes

Info

Publication number
CO2019012771A2
CO2019012771A2 CONC2019/0012771A CO2019012771A CO2019012771A2 CO 2019012771 A2 CO2019012771 A2 CO 2019012771A2 CO 2019012771 A CO2019012771 A CO 2019012771A CO 2019012771 A2 CO2019012771 A2 CO 2019012771A2
Authority
CO
Colombia
Prior art keywords
analytes
microbes
quantify
trace
detect
Prior art date
Application number
CONC2019/0012771A
Other languages
Spanish (es)
Inventor
Paul Zorner
Eric J Mathur
Josh Collins
Howard Bell
Scott Alan Shibata
Original Assignee
Locus Agriculture Ip Co Llc
Intelligent Mat Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locus Agriculture Ip Co Llc, Intelligent Mat Solutions Inc filed Critical Locus Agriculture Ip Co Llc
Publication of CO2019012771A2 publication Critical patent/CO2019012771A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/155—Particles of a defined size, e.g. nanoparticles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Nanotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

La presente invención proporciona métodos y ensayos para la detección multiplexada de analitos usando nanocristales que son uniformes en morfología, tamaño y composición en función de sus características ópticas únicas. Los métodos y ensayos descritos son particularmente útiles para la detección de microbios y/o agentes a base de microbios en una muestra ambiental compleja.The present invention provides methods and assays for multiplexed detection of analytes using nanocrystals that are uniform in morphology, size, and composition based on their unique optical characteristics. The methods and assays described are particularly useful for the detection of microbes and / or microbe-based agents in a complex environmental sample.

CONC2019/0012771A 2017-05-18 2019-11-15 Diagnostic assays to detect, quantify, and / or trace microbes and other analytes CO2019012771A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762507895P 2017-05-18 2017-05-18
PCT/US2018/033222 WO2018213604A2 (en) 2017-05-18 2018-05-17 Diagnostic assays for detecting, quantifying, and/or tracking microbes and other analytes

Publications (1)

Publication Number Publication Date
CO2019012771A2 true CO2019012771A2 (en) 2020-04-01

Family

ID=64274881

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2019/0012771A CO2019012771A2 (en) 2017-05-18 2019-11-15 Diagnostic assays to detect, quantify, and / or trace microbes and other analytes

Country Status (17)

Country Link
US (2) US20200102602A1 (en)
EP (1) EP3625563A4 (en)
JP (1) JP2020521127A (en)
KR (1) KR20200011456A (en)
CN (1) CN111051884A (en)
AU (1) AU2018269715A1 (en)
BR (1) BR112019024200A2 (en)
CA (1) CA3063714A1 (en)
CL (1) CL2019003286A1 (en)
CO (1) CO2019012771A2 (en)
CR (1) CR20190574A (en)
EA (1) EA201992748A1 (en)
MX (1) MX2019013724A (en)
PE (1) PE20200479A1 (en)
PH (1) PH12019502558A1 (en)
WO (1) WO2018213604A2 (en)
ZA (1) ZA201907514B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020022643A2 (en) 2018-05-08 2021-05-04 Locus Agriculture Ip Company, Llc microbe-based products to enhance plant root health and immunity
US20220228198A1 (en) * 2019-05-28 2022-07-21 Chan Zuckerberg Biohub, Inc. Method for multiplexed detection of nucleic acids using spectrally encoded beads
US11692989B2 (en) 2019-07-11 2023-07-04 Locus Solutions Ipco, Llc Use of soil and other environmental data to recommend customized agronomic programs
KR102388753B1 (en) 2020-07-20 2022-04-20 광주과학기술원 An apparatus for microorganism detection using dielectrophoresis force
US20230288337A1 (en) * 2020-08-04 2023-09-14 University Of Technology Sydney High dimensional fingerprints of single nanoparticles and their use in multiplexed digital assays
CN112198133A (en) * 2020-10-20 2021-01-08 上海洞舟实业有限公司 Preparation method of infrared laser visual detector
CN112382510B (en) * 2020-10-23 2022-07-05 华中科技大学 Near-infrared light catalytic electrode, preparation method and application
KR102613085B1 (en) 2020-11-26 2023-12-12 광주과학기술원 System for detecting microorganism
CN112710845B (en) * 2020-12-16 2023-07-07 北京热景生物技术股份有限公司 Kit for detecting neutralizing antibody of novel coronavirus and detection method
WO2022141230A1 (en) * 2020-12-30 2022-07-07 北京化工大学 Multiplex nucleic acid detection method based on gold nanoparticles
EP4279923A1 (en) * 2021-01-15 2023-11-22 Asahi Kasei Kabushiki Kaisha Method and kit for detecting presence and/or amount of bacteria in food/drink sample, environmental sample, or biological sample
KR20230114664A (en) 2022-01-25 2023-08-01 광주과학기술원 Microbial concentration detection element in unknown solution

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
WO2000017103A2 (en) * 1998-09-18 2000-03-30 Massachusetts Institute Of Technology Inventory control
AU4701200A (en) * 1999-05-07 2000-11-21 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US20020004246A1 (en) * 2000-02-07 2002-01-10 Daniels Robert H. Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
US20050208593A1 (en) * 2004-03-19 2005-09-22 Arizona Board Of Regents, Acting For And On Behalf Of Northern Arizona University Lateral flow diagnostic assay reader with radial cassette
AU2006311583A1 (en) * 2005-11-09 2007-05-18 Primeradx, Inc. Multiplexed quantitative detection of pathogens
US20090047673A1 (en) * 2006-08-22 2009-02-19 Cary Robert B Miniaturized lateral flow device for rapid and sensitive detection of proteins or nucleic acids
KR20080030555A (en) * 2007-12-04 2008-04-04 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Novel water-soluble nanocrystals comprising a polymeric coating reagent, and methods of preparing the same
US20110160090A1 (en) * 2008-05-05 2011-06-30 Los Alamos National Laboratory Nanocrystal-Based Lateral Flow Microarrays and Low-Voltage Signal Detection Systems
US7910309B2 (en) * 2008-07-31 2011-03-22 Los Alamos National Security, Llc Multiplexed lateral flow microarray assay for detection of citrus pathogens Xylella fastidiosa and Xanthomonas axonopodis pv citri
US10054593B2 (en) * 2015-06-05 2018-08-21 Intelleigent Material Solutions, Inc. Multiplexed spectral lifetime detection of phosphors
US10224398B2 (en) * 2010-12-28 2019-03-05 Life Technologies Corporation Preparation of nanocrystals with mixtures of organic ligands
CN102199428B (en) * 2011-04-11 2013-07-10 复旦大学 Rare earth-doped upconversion nanometer crystal-based fluorescent coding microspheres and preparation method thereof
US20140170674A1 (en) * 2012-01-02 2014-06-19 Aimin He Membraine-Based Assay Devices Utilizing Time-Resolved Up-Converting Luminescence
SG10201500862RA (en) * 2014-02-04 2015-09-29 Agency Science Tech & Res A Method for Detecting a Target Analyte

Also Published As

Publication number Publication date
AU2018269715A1 (en) 2020-01-16
WO2018213604A3 (en) 2018-12-27
BR112019024200A2 (en) 2020-06-02
EA201992748A1 (en) 2020-03-16
ZA201907514B (en) 2022-03-30
CN111051884A (en) 2020-04-21
PE20200479A1 (en) 2020-03-03
PH12019502558A1 (en) 2021-01-25
KR20200011456A (en) 2020-02-03
CR20190574A (en) 2020-04-03
US20230025938A1 (en) 2023-01-26
JP2020521127A (en) 2020-07-16
MX2019013724A (en) 2020-07-20
CA3063714A1 (en) 2018-11-22
EP3625563A2 (en) 2020-03-25
US20200102602A1 (en) 2020-04-02
CL2019003286A1 (en) 2020-07-24
EP3625563A4 (en) 2021-02-24
WO2018213604A2 (en) 2018-11-22

Similar Documents

Publication Publication Date Title
CO2019012771A2 (en) Diagnostic assays to detect, quantify, and / or trace microbes and other analytes
BR112018072627A2 (en) performing optical measurements on a sample
CL2017001940A1 (en) Soil quality measuring device
GB2556004A (en) Markers of stroke and stroke severity
BR112016019836A2 (en) method for analyzing a subject sample, diagnostic device for use in diagnosing endometriosis, kit, use of a biomarker, and method for increasing an antibody response in a subject
BR112017010406A2 (en) high throughput high performance liquid chromatography testing process
BR112016007106A2 (en) improved pregnancy test device and method
CO2018013670A2 (en) Image validation automation
ECSP13013092A (en) TEST OF LISYLOXIDASE-HOMOLOGIST 2 AND METHODS OF USE OF THE SAME
CR20110567A (en) DEVICES FOR DIAGNOSIS AND RELATED METHODS
BR112016008970A2 (en) EX VIVO ACTIVATION METHOD AND TO EVALUATE PLASMA ACTIVATION IN AN INDIVIDUAL, EX VIVO ASSAY TO DETERMINE PLASMA KALLICREIN ACTIVITY IN A SAMPLE
CR20150247A (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
AR102517A1 (en) TESTS TO DETECT IMMUNE SUBGROUPS OF T-CELLS AND THEIR METHODS OF USE
BR112017003895B8 (en) SAMPLE TESTING APPARATUS
CL2017002101A1 (en) Device, platform and assay for cell evaluation
TR201907737T4 (en) Crash test method of structural member using test specimen support and crash test apparatus and brace
EA201500080A1 (en) METHOD IN VITRO DIAGNOSIS AND MONITORING OF CANCER
CO2019002607A2 (en) Biomarkers of metabolites for diseases associated with the contact activation system
UY36223A (en) TEST DEVICES, METHODS FOR TESTING, TEST KITS AND METHOD FOR MANUFACTURING TEST DEVICES
CO2019002608A2 (en) Arn biomarkers for hereditary angioedema
BR112016024730A2 (en) immunochromatographic analysis device, method and kit
CO2019008675A2 (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
GB2545850A (en) System and method using a combined modality optical probe
BR112017006315A2 (en) therapeutic agent, use of a therapeutic agent, in vitro methods for determining whether a subject with melanoma has a higher risk of metastasis, determining a treatment regimen for a subject suffering from melanoma, treating a subject suffering from melanoma, in vitro test to predict increased risk of metastasis and kits
IL236836B (en) Optical method and system for measuring isolated features of a structure